Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for N2-3 Nasopharyngeal Carcinoma
NCT03290820Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
aspirin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03290820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290820.